Vivus

Biotech Calendar: Key Dates for December
TheStreet.com
Mon, 11/30/09 - 11:02 am
Exelixis
Dyax
OSI Pharmaceuticals
Isis Pharmaceuticals
Somaxon
Gilead Sciences
Eli Lilly
Vion Pharmaceuticals
Roche
Immunogen
Auxilium
BioDelivery Sciences
Arena Pharmaceuticals
Vivus
Synta
Vivus Erection Drug Worked Within 30 Minutes in Study
Bloomberg
Wed, 11/18/09 - 09:05 am
erectile dysfunction
Vivus
Avanafil
Vivus, Analyst in Obesity Drug Side-Effect Spat
TheStreet.com
Wed, 10/28/09 - 08:15 am
obesity
side effects
Vivus
Orexigen
Arena Pharmaceuticals
Qnexa
[video] Vivus CEO on Diet Drug
CNBC
Mon, 10/26/09 - 11:41 am
Vivus
obesity
Qnexa
Pharma CEOs
Leland WIlson
Why Estimates of Future Revenues for Obesity Drugs Are Likely Off the Mark
BNET Pharma
Mon, 10/19/09 - 06:45 pm
obesity
Qnexa
Vivus
Arena Pharmaceuticals
Orexigen
Contrave
Why Orexigen's Empatic News Is Good
Seeking Alpha
Fri, 10/2/09 - 10:29 am
Orexigen
obesity
Empatic
Arena Pharmaceuticals
Vivus
Surviving Wednesday's Wild Ride in Healthcare and Biotech
Seeking Alpha
Thu, 10/1/09 - 10:41 am
biotech
Caraco
Senomyx
Sucampo
Orexigen
Vivus
Sequenom
Biocryst
Orexigen, Vivus shares rise on obesity drug data
Yahoo/AP
Wed, 09/30/09 - 03:51 pm
Orexigen
Vivus
obesity
Empatic
Qnexa
Arena's Lorcaserin Has Safety Edge
Yahoo/Zacks.com
Mon, 09/21/09 - 10:13 am
Arena Pharmaceuticals
lorcaserin
obesity
Vivus
Orexigen
Vivus expects to raise $94.5M from stock offering
Yahoo/Zacks.com
Fri, 09/18/09 - 10:55 am
Vivus
stock offering
Qnexa
A Rise For Biopharma In The Fall?
CNBC
Wed, 09/16/09 - 04:25 pm
biotech
Arena Pharmaceuticals
Orexigen
Vivus
Amgen
Celgene
Vivus Can Teach Old Drugs New Tricks, But Does It Have a Bidil Problem?
InVivo
Wed, 09/16/09 - 09:12 am
Vivus
Qnexa
Bidil
obesity
Analyst thinks sales of Arena's lorcaserin will trail other obesity drugs, downgrades stock
Yahoo/AP
Wed, 09/16/09 - 09:11 am
downgrades
Arena Pharmaceuticals
obesity
lorcaserin
Vivus
Orexigen
Vivus: A One Trick Pony
Seeking Alpha
Fri, 09/11/09 - 08:20 am
Vivus
Arena Pharmaceuticals
Orexigen
obesity
Qnexa
Vivus's Qnexa Drug Approval Makes It a Nice Trade
Seeking Alpha
Thu, 09/10/09 - 10:37 am
Vivus
obesity
Qnexa
Vivus' obesity drug candidate hits weight reduction goals in 2 late-stage studies; shares soar
Yahoo/AP
Wed, 09/9/09 - 08:28 am
Vivus
obesity
Qnexa
Hot Biotech Events for Next Week: BioBuzz
TheStreet.com
Fri, 09/4/09 - 08:49 am
biotech
Elan
Geron
Cell Therapeutics
Genta
Antigenics
Vivus
Osiris Therapeutics
Weighing Arena's Obesity Drug: Biotech Mailbag
TheStreet.com
Fri, 09/4/09 - 07:42 am
Arena Pharmaceuticals
obesity
Biovest International
Vivus
Orexigen
Qnexa
lorcaserin
Vivus: Obesity Experimental Drug Has Promising Outlook
Seeking Alpha
Wed, 07/8/09 - 09:17 am
Vivus
obesity
Qnexa
Extreme FDA Trades: Another 18 Stocks Under 5 Bucks
Seeking Alpha
Sun, 07/5/09 - 08:42 am
Javelin
Acrux
Arena Pharmaceuticals
Cardium
Vivus
Orexigen
Biodel
Avanir
Alexza
Acadia
GenVec
Celsion
Antigenics
Osteotech
Transdel
pSivida
ARYx
Chelsea Therapeutics
CytRx
Human Genome Sciences

Pages